Palencia VRJ, Palencia DR

Language: Spanish
References: 19
Page: 482-488
PDF size: 840.31 Kb.

ABSTRACT

Pneumonia is an infection of parenchymal lung with high morbidity and mortality, characterized primarily by respiratory manifestations, fever and radiological findings. Most common etiology are bacteria and viruses, both difficult to differentiate clinically, with etiological and clinical behavior according to age groups and likely sites where the infection was acquired (community-acquired pneumonia and hospital-acquired pneumonia). Atypical pneumonia describes an unusual presentation of pneumonia. The term in its broadest meaning described a pneumonia caused by a group of relatively common pathogens (Mycoplasma pneumoniae, Chlamydophila pneumoniae, Legionella spp and some viruses).

REFERENCES

1. MeIntosh K. Community-adquired pneumonia in children. N Engl J Med 2002;346:429-437.

2. Michelow IC, Olsen K, Lozano J, et al. Epidemiology and clinical characteristics of community-adquired pneumonia in hospitalized children. Pediatrics 2004;113:701-707.

3. Murdoch DR, Chambers ST. Atypical pneumonia-time to breathe new life into a useful term? Lancet Infect Dis 2009;9:512-519.

4. Baer G, Engelcke G, Abele-Horn M, et al. Role de Chlamydia pneumoniae y Mycoplasma pneumoniae as causative agents of community-acquired pneumonia in hospitalized children and adolescents. Eur J Clin Microbiol Infect Dis 2003;22:742-745.

5. Burroughs M, Horga MA, Murrell MT, Moscona A. Respiratory infections. In: Gershon AA, Hotez PJ, Kataz SL, editors. Krugman’s Infectious Disease of Children. 11th ed. Philadelphia: Mosby, 2004;493-529.

6. Isaacs D. Problems in determining the etiology of community- acquired childhood pneumonia. Pediatr Infect Dis J 1989;8:143-148.

7. Del Castillo MartÍn F, García Miguel MJ, García García S. Manejo racional de la neumonía aguda de la comunidad. An Esp Pediatr 1999;51:609-616.

8. García-Miguel MJ, Méndez-Echevarría A. Neumonía aguda. En: Muñoz Calvo MT, Hidalgo Vicario MI, Clemente Pollán J, editores. Pediatría Extrahospitalaria. 4ª ed. Madrid: Ergon, 2008;299-302.

9. Hazir T, Fox LM, Nisar YB, et al. Ambulatory short-course high-dose oral amoxicillin or treatment of severe pneumonia in children: a randomised equivalency trial. Lancet 2008;371:49-56.

10. Virkki R, Juven T, Rikalainen H, et al. Differentiation of bacterial and viral pneumonia in children. Thorax 2002;57:438-441.

11. Korppi M, Don M, Valent F, et al. The value of clinical features in differentiating between viral, pneumococcal and atypical bacterial pneumonia in children. Acta Paediatr 2008;97:943-947.

12. Bradley JS, Byington CL, Shah SS, et al. The management of community acquired pneumonia in infants and children 488 Medicina Interna de México Volumen 30, Núm. 4, julio-agosto, 2014 older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis 2011;53:e25-76.

13. Committee on Infectious Diseases. The use of systemic fluoroquinolones. Pediatrics 2006;118:1287-1292.

14. Bradley JS, Arguedas A, Blumer JL, et al. Comparative study of levofloxacin in the treatment of children with community-acquired pneumonia. Pediatr Infect Dis J 2007;26:868-878.

15. Iroh Tam PY. Approach to common bacterial infections: Community-Acquiered Pneumonia. Pediatr Clin North Am 2013;60:437-453.

16. Bradley JS, McCracken GH. Unique considerations in the evaluation of antibacterials in clinical trials for pediatric community-acquired pneumonia. Clinical Infectious Diseases 2008;47:S241-248.

17. Grant GB, Campbell H, Dowell SF, Graham SM, et al. Recommendations for treatment of childhood non-severe pneumonia. Lancet Infect Dis 2009;9:185-196.

18. Eslamy HK, Newman B. Pneumonia in normal and immunocompromised children: An overview and update. Radiol Clin N Am 2011;49:895-920.

19. Wolf J, Daley AJ. Microbiological aspects of bacterial lower respiratory tract illness in children: atypical pathogens. Paediatr Resp Rev 2007;8:212-220.